Bepirovirsen reduced posttreatment markers of hepatitis B infection at 72 weeks, with 20% of recipie...
Functional Cure for Hepatitis B Is Now ‘Achievable’
Bepirovirsen reduced posttreatment markers of hepatitis B infection at 72 weeks, with 20% of recipients achieving functional cure vs none given placebo.
Author: Medscape
Read Original Article